Pfizer on Tuesday forecast modest 2026 guidance as it looks to longer-term investments in its pipeline to counter waning Covid product sales and declines from older drugs.Those hurdles aren't surprising or new for Pfizer, which has seen a dramatic decline in Covid vaccine and antiviral sales after raking in record-setting revenue during the pandemic. The drugmaker has pursued deals of all sizes in recent years to build new revenue streams, such as its recently closed $10 billion acquisition of the obesity b ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

That’s incredible. The FDA’s Chief Medical and Scientific Officer studied 96 child deaths between 2021-2024 and attributed 10 child deaths to the Covid vaccine. That puts the Covid vaccine death rate at 10.42% for kids.Chief Nerd (@TheChiefNerd):🚨 The headline from the alleged Dr Prasad internal email is that at least 10 children’s deaths were related to COVID vaccination.However reading his full email, it mentions that those 10 were only after an INITIAL analysis of 96 deaths. That’s at least 10%.There wer ...

Safety Concerns - The report alleges that the Covid vaccine caused deaths in children, citing an email circulating within the FDA [1] - The report references the FDA's Chief Medical and Scientific Officer and Director of the FDA's Center for Biologics Evaluation and Research in relation to the alleged vaccine deaths [1] Source and Credibility - The information is attributed to an email circulating inside the FDA, shared by Jeffrey A Tucker [1] - The report questions the truthfulness and reliability of the information presented in the email [1]

Thursday, November 6, 2025Pre-market indexes are bounding into positive territory at this hour, after wallowing in the red following yesterday’s solid gains. One might say the relative volatility we started seeing in early October — back when the government shutdown first happened — has continued into this month as well.Only the small-cap Russell 2000 has been positive over the past five trading days, but only the Russell is negative among major indexes over the past month. Currently, the Dow is up +0.10%, ...

Moderna cut the top end of its full-year revenue forecast for a second straight quarter, a sign that new US Covid vaccine policies are hurting demand for the company’s main product https://t.co/wDR8cgXh1J ...

Core Insights - Moderna Inc. shares increased after reporting a narrower third-quarter loss than anticipated, indicating effective cost-cutting measures amid declining Covid vaccine sales [1][2] - The company aims to break even by 2028, despite a significant 45% year-over-year decline in third-quarter sales, which totaled $1 billion, primarily from its Covid vaccine [2][3] Financial Performance - The net loss for the third quarter was 51 cents per share, significantly better than Wall Street's expectation of a loss of $2.21 [1] - Third-quarter sales of $1 billion exceeded analysts' expectations, despite a 45% decline from the previous year [2] - Moderna's projected sales for the year are now between $1.6 billion and $2 billion, a reduction from the previous forecast that reached up to $2.2 billion [4] Market Context - Moderna shares rose 4.4% in premarket trading, although they have declined 43% year-to-date, contrasting with a nearly 16% gain in the S&P 500 index [3] - The company has faced challenges due to reduced demand for Covid vaccines and confusion surrounding federal vaccination policies [3][6] Regulatory Environment - The third quarter marked the beginning of the US vaccination season, revealing the impact of new guidelines that limit access to Covid vaccines [6] - The Advisory Committee on Immunization Practices recommended ending universal access to Covid shots, requiring individuals to consult medical professionals before vaccination [7]

RT yosoymario (@yosoymario91)My wife, who’s a doctor looked at me while injecting myself with grey market Chinese peptides and said “but you didn’t get the fucking Covid vaccine”. You bet I didn’t girl. ...

Healthcare Access - Covid vaccine availability may vary based on location or pharmacy [1]

A week of shifting rules and escalating political rhetoric has left millions of Americans grappling with a simple health-care question: Can I get the Covid vaccine or not? https://t.co/t02DnWLrHr ...